Page last updated: 2024-10-21

3-aminobenzamide and Neoplasms

3-aminobenzamide has been researched along with Neoplasms in 11 studies

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19903 (27.27)18.7374
1990's2 (18.18)18.2507
2000's4 (36.36)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diamandis, P1
Wildenhain, J1
Clarke, ID1
Sacher, AG1
Graham, J1
Bellows, DS1
Ling, EK1
Ward, RJ1
Jamieson, LG1
Tyers, M1
Dirks, PB1
Lin, R1
Elf, S1
Shan, C1
Kang, HB1
Ji, Q1
Zhou, L1
Hitosugi, T1
Zhang, L1
Zhang, S1
Seo, JH1
Xie, J1
Tucker, M1
Gu, TL1
Sudderth, J1
Jiang, L1
Mitsche, M1
DeBerardinis, RJ1
Wu, S1
Li, Y1
Mao, H1
Chen, PR1
Wang, D1
Chen, GZ1
Hurwitz, SJ1
Lonial, S1
Arellano, ML1
Khoury, HJ1
Khuri, FR1
Lee, BH1
Lei, Q1
Brat, DJ1
Ye, K1
Boggon, TJ1
He, C1
Kang, S1
Fan, J1
Chen, J1
DonĂ , F1
Chiodi, I1
Belgiovine, C1
Raineri, T1
Ricotti, R1
Mondello, C1
Scovassi, AI1
Wedge, SR1
Porteous, JK1
Newlands, ES1
Nagao, M1
Nakayasu, M1
Aonuma, S1
Shima, H1
Sugimura, T1
Thraves, PJ2
Mossman, KL2
Brennan, T1
Dritschilo, A2
Kelland, LR1
Burgess, L1
Steel, GG1
Frazier, DT1
Haince, JF1
Rouleau, M1
Hendzel, MJ1
Masson, JY1
Poirier, GG1
Sheridan, C1
Robins, P1

Reviews

3 reviews available for 3-aminobenzamide and Neoplasms

ArticleYear
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Nature cell biology, 2015, Volume: 17, Issue:11

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms;

2015
Poly(ADP-ribosylation) and neoplastic transformation: effect of PARP inhibitors.
    Current pharmaceutical biotechnology, 2013, Volume: 14, Issue:5

    Topics: Animals; Benzamides; Cell Transformation, Neoplastic; Humans; Neoplasms; Poly(ADP-ribose) Polymerase

2013
Targeting poly(ADP-ribosyl)ation: a promising approach in cancer therapy.
    Trends in molecular medicine, 2005, Volume: 11, Issue:10

    Topics: DNA Repair; Gene Components; Heterocyclic Compounds, 4 or More Rings; Humans; Indoles; Models, Molec

2005

Other Studies

8 other studies available for 3-aminobenzamide and Neoplasms

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic

2007
3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity.
    British journal of cancer, 1996, Volume: 74, Issue:7

    Topics: Antineoplastic Agents, Alkylating; Benzamides; Carmustine; Dacarbazine; DNA Repair; Drug Screening A

1996
Loss of amplified genes by poly(ADP-ribose) polymerase inhibitors.
    Environmental health perspectives, 1991, Volume: 93

    Topics: 3T3 Cells; Aminobenzoates; Animals; Benzamides; Benzoates; Benzoic Acid; Cell Differentiation; Cell

1991
Differential radiosensitization of human tumour cells by 3-aminobenzamide and benzamide: inhibitors of poly(ADP-ribosylation).
    International journal of radiation biology and related studies in physics, chemistry, and medicine, 1986, Volume: 50, Issue:6

    Topics: Benzamides; Cell Line; Cell Survival; DNA Repair; Humans; Neoplasms; Poly(ADP-ribose) Polymerase Inh

1986
Differential radiosensitization by the poly(ADP-ribose) transferase inhibitor 3-aminobenzamide in human tumor cells of varying radiosensitivity.
    International journal of radiation oncology, biology, physics, 1988, Volume: 14, Issue:6

    Topics: Benzamides; Cell Line; Cell Survival; DNA Repair; DNA, Neoplasm; Dose-Response Relationship, Drug; D

1988
Inhibition of potentially lethal radiation damage repair in normal and neoplastic human cells by 3-aminobenzamide: an inhibitor of poly(ADP-ribosylation).
    International journal of radiation oncology, biology, physics, 1986, Volume: 12, Issue:8

    Topics: Benzamides; Cell Line; Cell Survival; DNA Repair; Humans; In Vitro Techniques; Neoplasms

1986
Genentech raises stakes on PARP inhibitors.
    Nature biotechnology, 2006, Volume: 24, Issue:10

    Topics: Drug Evaluation, Preclinical; Drug Industry; Enzyme Inhibitors; Humans; Indoles; Neoplasms; Poly(ADP

2006
JPMorgan 25th annual healthcare conference. R&D at Merrimack, Inotek and Gemin X.
    IDrugs : the investigational drugs journal, 2007, Volume: 10, Issue:3

    Topics: Delivery of Health Care; Drug Industry; Humans; Indoles; Neoplasms; Poly(ADP-ribose) Polymerase Inhi

2007